USE OF RENIN-ANGIOTENSIN ANTAGONIST FOR REDUCING POST MYOCARDIAL INFARCT MOBIDITY AND MORTALITY

摘要

The invention involves a method for treating a human survivor of a heart attack and provides further improvement in survival following the heart attack by the early initiation and long-term administration of a renin-angiotensin system inhibitor, preferably an angiotensin converting enzyme inhibitor. The inhibitor may be used on its own, or in conjunction with other therapeutic compounds such as beta blockers and thrombolytic agents. The preferred inhibitor is captopril.